Clinical Trial: Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma
This open-label, Phase 2 study is studying whether the monoclonal antibody Avelumab, in combination with radiation therapy, is safe in the treatment of relapsed/refractory myeloma. Open-Label: Patients and their doctors will know both the treatment and the dose that they will be receiving. One of the ways that cancer cells have learned to protect themselves is by using